Australia markets close in 39 minutes

Monte Rosa Therapeutics, Inc. (GLUE)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
5.76+0.11 (+1.95%)
At close: 04:00PM EDT
5.89 +0.13 (+2.26%)
After hours: 04:15PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-101,159
-135,352
-108,501
-73,958
-35,879
Depreciation & amortisation
3,484
6,222
3,745
2,132
537
Stock-based compensation
10,194
16,669
11,664
5,200
354
Change in working capital
2,392
72,466
-2,134
6,286
4,255
Accounts payable
3,841
5,758
-744
-706
3,435
Other working capital
-91,376
-62,843
-105,377
-69,095
-26,442
Other non-cash items
3,202
-
4,814
960
7,680
Net cash provided by operating activities
-82,677
-43,802
-92,466
-59,363
-23,053
Cash flows from investing activities
Investments in property, plant and equipment
-8,699
-19,041
-12,911
-9,732
-3,389
Purchases of investments
-103,151
-103,151
-384,417
0
-
Sales/maturities of investments
210,931
210,931
178,000
0
-
Net cash used for investing activities
-168,327
88,801
-219,219
-9,653
-3,389
Cash flows from financing activities
Common stock issued
0
0
20,055
237,750
0
Common stock repurchased
-
-
-
-
-440
Other financing activities
-452
-116
-364
-3,337
-440
Net cash used provided by (used for) financing activities
-103
27,492
20,466
377,562
60,060
Net change in cash
-251,107
72,491
-291,219
308,546
33,618
Cash at beginning of period
368,763
60,190
351,409
42,863
9,245
Cash at end of period
117,656
132,681
60,190
351,409
42,863
Free cash flow
Operating cash flow
-82,677
-43,802
-92,466
-59,363
-23,053
Capital expenditure
-8,699
-19,041
-12,911
-9,732
-3,389
Free cash flow
-91,376
-62,843
-105,377
-69,095
-26,442